Skip to main content

stock

ASND · Ascendis Pharma A/S

What Ascendis Pharma A/S reports to the SEC, read from its filings.

Open in the app

Price

The live ASND price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ASND.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
61,977,408 as of 2025-12-31 (XBRL frame CY2025Q4I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
—

Health

Current ratio
—
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at —.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

No quarterly results reported by SEC for this filer.

Assets (not reported by this company)
—Assets: unreported by this company.
Equity (not reported by this company)
—Equity: unreported by this company.

Ten years

No annual results reported by SEC for this filer.

Company filings

5% owners ()

  • Artisan Partners Asset Management Inc.

    Stake update

    4.2%Aug 13SCHEDULE 13G/A
  • JANUS HENDERSON GROUP PLC

    Stake update

    6.0%May 15SCHEDULE 13G/A
  • Capital International Investors

    Stake update

    3.2%May 14SCHEDULE 13G/A
  • T. Rowe Price Investment Management, Inc.

    Stake update

    10.5%May 7SCHEDULE 13G/A
  • T. Rowe Price Investment Management, Inc.

    Passive stake

    9.9%May 7SCHEDULE 13G

Insiders, politicians and funds

Insider trades, last 90 days

  • Bodenhoff Mads

    SVP & PAO

    Sale$810,570

    Sep 9, 5:04 PM ET

  • HOLTUG LARS

    Director

    Sale$62,335

    Sep 3, 4:09 PM ET

  • BIENAIME JEAN JACQUES

    Director

    Buy$492,654

    Aug 18, 9:02 PM ET

All insider trades for ASND

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ASND, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ASND.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ASND.

nakagai

Signals on ASND come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ASND board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Ascendis Pharma A/S (ASND): SEC filings, financials and insider trades · Nakagai